Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Crocus Sativus Extract in Obesity and Prediabetes
NCT07261475Phase 1Recruiting
- Sponsor
- University of Primorska
- Start
- Feb 2026
- Primary completion
- Jun 2026
- Modality
- Biologic
- Countries
- 1
01
Overview
Phase 1, randomised trial of Crocus sativus tepal extract in prediabetes and obesity (2 arms), sponsored by University of Primorska. Primary endpoint: Glucose levels at 120 months. Started Feb 2026; status: recruiting.
02
Drugs
Crocus sativus tepal extract
03
Conditions
prediabetesobesity
Beyond the preview
Go deeper on NCT07261475.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07261475.